Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""KANJI, Salmaan"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-19 z 19
    Tytuł:
    Clinical utility of overviews on adverse events of pharmacological interventions.
    Autorzy:
    Sachse T; Faculty of Health, School of Medicine, Institute for Research in Operative Medicine, Witten/Herdecke University, 51109, Cologne, Germany. .
    Kanji S; The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Thabet P; Hôpital Montfort and University of Ottawa, Ottawa, Ontario, Canada.
    Schmiedl S; Philipp Klee-Institute of Clinical Pharmacology, Helios University Hospital Wuppertal, Witten/Herdecke University, Chair of Clinical Pharmacology, Wuppertal, Germany.
    Thürmann P; Philipp Klee-Institute of Clinical Pharmacology, Helios University Hospital Wuppertal, Witten/Herdecke University, Chair of Clinical Pharmacology, Wuppertal, Germany.
    Guirguis F; The Ottawa Hospital, Ottawa, Ontario, Canada.
    Sajwani S; The Ottawa Hospital, Ottawa, Ontario, Canada.
    Gauthier MF; Hôpital Montfort and University of Ottawa, Ottawa, Ontario, Canada.
    Lunny C; Knowledge Translation Program, Unity Health Toronto and the Cochrane Hypertension Group, St. Michael's Hospital, University of British Columbia, Vancouver, Canada.
    Mathes T; Faculty of Health, School of Medicine, Institute for Research in Operative Medicine, Witten/Herdecke University, 51109, Cologne, Germany.; Institute for Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
    Pieper D; Faculty of Health, School of Medicine, Institute for Research in Operative Medicine, Witten/Herdecke University, 51109, Cologne, Germany.; Faculty of Health Sciences Brandenburg, Brandenburg Medical School (Theodor Fontane), Institute for Health Services and Health System Research, Rüdersdorf, Germany.; Center for Health Services Research, Brandenburg Medical School (Theodor Fontane), Rüdersdorf, Germany.
    Pokaż więcej
    Źródło:
    Systematic reviews [Syst Rev] 2023 Jul 31; Vol. 12 (1), pp. 131. Date of Electronic Publication: 2023 Jul 31.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Delivery of Health Care*
    Publications*
    Humans ; Health Facilities ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.
    Autorzy:
    Wolfe D; Ottawa Hospital Research Institute, Ottawa, Canada.
    Corace K; Institute of Mental Health Research at The Royal, University of Ottawa, Ottawa, Canada.; Department of Family Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
    Butler C; Ottawa Hospital Research Institute, Ottawa, Canada.
    Rice D; Ottawa Hospital Research Institute, Ottawa, Canada.
    Skidmore B; Ottawa Hospital Research Institute, Ottawa, Canada.
    Patel Y; Ottawa Hospital Research Institute, Ottawa, Canada.
    Thayaparan P; Ottawa Hospital Research Institute, Ottawa, Canada.
    Michaud A; Ottawa Hospital Research Institute, Ottawa, Canada.
    Hamel C; Ottawa Hospital Research Institute, Ottawa, Canada.
    Smith A; School of Psychology, Faculty of Social Sciences, University of Ottawa, Ottawa, Canada.
    Garber G; Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
    Porath A; Canadian Center for Substance Use and Addiction, Ottawa, Canada.
    Conn D; Department of Psychiatry, University of Toronto, Toronto, Canada.; Baycrest Health Sciences, Toronto, Canada.
    Willows M; Institute of Mental Health Research at The Royal, University of Ottawa, Ottawa, Canada.; Department of Family Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.
    Abramovici H; Health Canada, Office of Cannabis Science and Surveillance, Ottawa, Canada.
    Thavorn K; Ottawa Hospital Research Institute, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
    Kanji S; Ottawa Hospital Research Institute, Ottawa, Canada.; Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
    Hutton B; Ottawa Hospital Research Institute, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2023 Feb 17; Vol. 18 (2), pp. e0281826. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023).
    Typ publikacji:
    Review; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Medical Marijuana*/adverse effects
    Cannabis*/adverse effects
    Neoplasms*/drug therapy
    Substance-Related Disorders*/drug therapy
    Humans ; Aged ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.
    Autorzy:
    Beck A; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. .
    Persaud N; Department of Family and Community Medicine, St. Michael's Hospital, Toronto, Ontario, Canada.
    Tessier LA; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
    Grad R; Department of Family Medicine, McGill University, Montreal, Quebec, Canada.
    Kidd MR; College of Health & Medicine, The Australian National University, Canberra, Australia.; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
    Klarenbach S; Department of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
    Korownyk C; Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada.
    Moore A; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
    Thombs BD; Lady Davis Institute of the Jewish General Hospital and Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
    Mangin D; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.; Department of General Practice, University of Otago, Dunedin, New Zealand.
    McCracken RK; Department of Family Practice, University of British Columbia, Vancouver, British Columbia, Canada.
    McDonald EG; Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
    Sirois C; Faculty of Pharmacy, Laval University; Centre d'excellence sur le vieillissement de Québec, VITAM research Centre, Québec, Québec, Canada.
    Kanji S; The Ottawa Hospital, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Molnar F; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Division of Geriatric Medicine, The Ottawa Hospital, The Ottawa Hospital Research Institute, Bruyere Research Institute, Ottawa, Ontario, Canada.
    Nicholls SG; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Thavorn K; Independent Information Specialist, Ottawa, Ontario, Canada.
    Bennett A; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Shaver N; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Skidmore B; Independent Information Specialist, Ottawa, Ontario, Canada.
    Mitchelmore BR; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
    Avey M; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
    Rolland-Harris E; Global Health and Guidelines Division, Public Health Agency of Canada, Ottawa, Ontario, Canada.
    Little J; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Moher D; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Pokaż więcej
    Źródło:
    Systematic reviews [Syst Rev] 2022 Oct 20; Vol. 11 (1), pp. 225. Date of Electronic Publication: 2022 Oct 20.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Inappropriate Prescribing*/prevention & control
    Quality of Life*
    Humans ; Adult ; Canada ; Bias ; Primary Health Care ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Additional considerations and response to 'graphical representation of overlap for OVErviews (GROOVE tool)'.
    Autorzy:
    Thabet P; Hôpital Montfort, Ottawa, Canada.; University of Ottawa, Ottawa, Canada.; The Ottawa Hospital, Ottawa, Canada.
    Kanji S; University of Ottawa, Ottawa, Canada.; The Ottawa Hospital, Ottawa, Canada.; The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Pieper D; Faculty of Health Sciences Brandenburg, Brandenburg Medical School (Theodor Fontane), Institute for Health Services and Health Systems Research, Rüdersdorf, Germany.; Center for Health Services Research, Brandenburg Medical School (Theodor Fontane), Rüdersdorf, Germany.
    Lunny C; St Michael's Hospital, Unity Health Toronto, Toronto, Canada.; Cochrane Hypertension Review Group, University of British Columbia, Vancouver, Canada.
    Pokaż więcej
    Źródło:
    Research synthesis methods [Res Synth Methods] 2022 Sep; Vol. 13 (5), pp. 548-551. Date of Electronic Publication: 2022 Jul 27.
    Typ publikacji:
    Letter
    MeSH Terms:
    Evidence-Based Medicine*
    Research Design*
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Managing overlap of primary study results across systematic reviews: practical considerations for authors of overviews of reviews.
    Autorzy:
    Lunny C; Cochrane Hypertension Group and the Therapeutics Initiative, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.
    Pieper D; Institute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany. .
    Thabet P; Hôpital Montfort, Ottawa, Canada.
    Kanji S; The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada.
    Pokaż więcej
    Źródło:
    BMC medical research methodology [BMC Med Res Methodol] 2021 Jul 07; Vol. 21 (1), pp. 140. Date of Electronic Publication: 2021 Jul 07.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Publications*
    Research Design*
    Bias ; Delivery of Health Care ; Humans ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study.
    Autorzy:
    Smith HA; Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada. .
    Kanji S; Department of Pharmacy, The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Canada.
    Tran DTT; Division of Cardiac Anesthesiology, Department of Anesthesiology & Pain Medicine, University of Ottawa Heart Institute, Ottawa, Canada.
    Redpath C; University of Ottawa Heart Institute, Ottawa, Canada.
    Ferguson D; Ottawa Hospital Research Institute, Ottawa, Canada.
    Lenet T; Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.
    Sigler G; Division of General Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.
    Gilbert S; Division of Thoracic Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.
    Maziak D; Division of Thoracic Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.
    Villeneuve P; Division of Thoracic Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.
    Sundaresan S; Division of Thoracic Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.
    Seely AJE; Division of Thoracic Surgery, Department of Surgery, University of Ottawa, Ottawa, Canada.; Division of Thoracic Surgery, Department of Surgery and Critical Care Medicine, University of Ottawa, Ottawa, Canada.
    Pokaż więcej
    Źródło:
    Trials [Trials] 2021 Jun 07; Vol. 22 (1), pp. 384. Date of Electronic Publication: 2021 Jun 07.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Amiodarone*/adverse effects
    Atrial Fibrillation*/diagnosis
    Atrial Fibrillation*/etiology
    Atrial Fibrillation*/prevention & control
    Anti-Arrhythmia Agents/therapeutic use ; Feasibility Studies ; Humans ; Multicenter Studies as Topic ; Postoperative Complications/drug therapy ; Postoperative Complications/etiology ; Postoperative Complications/prevention & control ; Postoperative Period ; Randomized Controlled Trials as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Delirium and Associated Length of Stay and Costs in Critically Ill Patients.
    Autorzy:
    Dziegielewski C; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Skead C; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Canturk T; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Webber C; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.; Bruyère Research Institute, Ottawa, ON, Canada.; ICES uOttawa, Ottawa, ON, Canada.
    Fernando SM; Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Department of Emergency Medicine, University of Ottawa, Ottawa, ON, Canada.
    Thompson LH; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
    Foster M; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
    Ristovic V; Department of Anesthesia, University of Ottawa, Ottawa, ON, Canada.
    Lawlor PG; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.; Bruyère Research Institute, Ottawa, ON, Canada.; Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Chaudhuri D; Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Dave C; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Herritt B; Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Bush SH; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.; Bruyère Research Institute, Ottawa, ON, Canada.; Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Kanji S; Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Pharmacy, Ottawa, ON, Canada.
    Tanuseputro P; Bruyère Research Institute, Ottawa, ON, Canada.; ICES uOttawa, Ottawa, ON, Canada.; Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Thavorn K; ICES uOttawa, Ottawa, ON, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; The Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Rosenberg E; Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Kyeremanteng K; Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Division of Palliative Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
    Pokaż więcej
    Źródło:
    Critical care research and practice [Crit Care Res Pract] 2021 Apr 24; Vol. 2021, pp. 6612187. Date of Electronic Publication: 2021 Apr 24 (Print Publication: 2021).
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: An overview of systematic reviews.
    Autorzy:
    Thabet P; The Ottawa Hospital, Ottawa, Ontario, Canada.
    Joshi A; University of Waterloo, Waterloo, Ontario, Canada.
    MacDonald E; The Ottawa Hospital, Ottawa, Ontario, Canada.
    Hutton B; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa School of Epidemiology and Public Health, Ottawa, Canada.
    Cheng W; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Stevens A; McMaster University, Hamilton, Ontario, Canada.
    Kanji S; The Ottawa Hospital, Ottawa, Ontario, Canada.; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; University of Ottawa School of Epidemiology and Public Health, Ottawa, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2021 Jan 22; Vol. 16 (1), pp. e0244966. Date of Electronic Publication: 2021 Jan 22 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Anti-Bacterial Agents/*pharmacokinetics
    beta-Lactams/*pharmacokinetics
    Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/drug therapy ; Humans ; Infusions, Intravenous ; Systematic Reviews as Topic ; Treatment Outcome ; beta-Lactams/administration & dosage ; beta-Lactams/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.
    Autorzy:
    Wolfe D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Kanji S; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Pharmacy, The Ottawa Hospital, Ottawa, Ontario, Canada.
    Yazdi F; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Barbeau P; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Rice D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Beck A; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Butler C; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Esmaeilisaraji L; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Skidmore B; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Moher D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Hutton B; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2020 Apr 17; Vol. 15 (4), pp. e0231883. Date of Electronic Publication: 2020 Apr 17 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
    MeSH Terms:
    Pancreatitis/*pathology
    Pharmaceutical Preparations/*classification
    Acute Disease ; Databases, Factual ; Drug-Related Side Effects and Adverse Reactions ; Humans ; Pancreatitis/chemically induced
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Lessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trial.
    Autorzy:
    Masse MH; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
    Ménard J; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
    Sprague S; Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
    Battista MC; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke Sherbrooke and Université de Sherbrooke, Sherbrooke, QC, Canada.
    Cook DJ; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
    Guyatt GH; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
    Heyland DK; Department of Critical Care Medicine, Queen's University, Kingston, ON, Canada.
    Kanji S; Departments of Pharmacy and Critical Care, The Ottawa Hospital and Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Pinto R; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
    Day AG; Kingston General Health Research Institute, Kingston, ON, Canada.
    Cohen D; No institutional affiliation, No institutional affiliation, Sherbrooke, QC, Canada.
    Annane D; General Intensive Care Unit, Raymond Poincaré Hospital (AP-HP), Lab Inflammation & Infection, U1173 University Paris Saclay-UVSQ/INSERM, Garches, France.
    McGuinness S; Cardiothoracic and Vascular ICU, Auckland City Hospital, Auckland, New Zealand.; Medical Research Institute of New Zealand, Wellington, New Zealand.
    Parke R; Cardiothoracic and Vascular ICU, Auckland City Hospital, Auckland, New Zealand.; Medical Research Institute of New Zealand, Wellington, New Zealand.; School of Nursing, The University of Auckland, Auckland, New Zealand.
    Carr A; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
    Arabi Y; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
    Vijayaraghavan BKT; Department of Critical Care Medicine, Apollo Hospitals, Chennai, India.
    D'Aragon F; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke Sherbrooke and Université de Sherbrooke, Sherbrooke, QC, Canada.
    Carbonneau É; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
    Maslove D; Department of Critical Care Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, ON, Canada.
    Hunt M; Department of Critical Care Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, ON, Canada.
    Rochwerg B; Department of Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
    Millen T; Juravinski Hospital, Hamilton, ON, Canada.
    Chassé M; Centre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, QC, Canada.
    Lebrasseur M; Centre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, QC, Canada.
    Archambault P; Faculté de Médecine, Université Laval, Québec City, QC, Canada.; Département des soins intensifs du Centre intégré de santé et des services sociaux de Chaudière-Appalaches (Secteur Alphonse-Desjardins), Lévis, QC, Canada.
    Deblois E; Département des soins intensifs du Centre intégré de santé et des services sociaux de Chaudière-Appalaches (Secteur Alphonse-Desjardins), Lévis, QC, Canada.
    Drouin C; Department of Critical Care Research, St. Joseph's Healthcare, Hamilton, ON, Canada.; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
    Lellouche F; Department of Medecine, Université Laval and Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Québec City, QC, Canada.
    Lizotte P; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, QC, Canada.
    Watpool I; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Porteous R; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Clarke F; Department of Critical Care Research, St. Joseph's Healthcare, Hamilton, ON, Canada.
    Marinoff N; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
    Belley-Côté É; Division of Cardiology, Department of Medicine, McMaster University, Population Health Research Institute, Hamilton, ON, Canada.
    Bolduc B; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.
    Walker S; Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, Canada and Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
    Iazzetta J; Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
    Adhikari NKJ; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. .; Interdepartmental Division of Critical Care Medicine and Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada. .
    Lamontagne F; Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke Sherbrooke and Université de Sherbrooke, Sherbrooke, QC, Canada. .
    Pokaż więcej
    Corporate Authors:
    Canadian Critical Care Trials Group
    Źródło:
    Trials [Trials] 2020 Jan 08; Vol. 21 (1), pp. 42. Date of Electronic Publication: 2020 Jan 08.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Antioxidants/*administration & dosage
    Ascorbic Acid/*administration & dosage
    Multiple Organ Failure/*epidemiology
    Sepsis/*drug therapy
    Vasoconstrictor Agents/*administration & dosage
    Acute Kidney Injury/chemically induced ; Acute Kidney Injury/epidemiology ; Administration, Intravenous ; Adult ; Antioxidants/adverse effects ; Ascorbic Acid/adverse effects ; Clinical Trials, Phase III as Topic ; Dose-Response Relationship, Drug ; Drug Therapy, Combination/adverse effects ; Drug Therapy, Combination/methods ; Female ; Hemolysis/drug effects ; Hospital Mortality ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemia/epidemiology ; Intensive Care Units/statistics & numerical data ; Male ; Middle Aged ; Multiple Organ Failure/etiology ; Multiple Organ Failure/prevention & control ; Quality of Life ; Sepsis/complications ; Sepsis/mortality ; Treatment Outcome ; Vasoconstrictor Agents/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Benefits and harms of medical cannabis: a scoping review of systematic reviews.
    Autorzy:
    Pratt M; Knowledge Synthesis Group, Ottawa Methods Centre, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ontario, K1H 8 L6, Canada.
    Stevens A; Knowledge Synthesis Group, Ottawa Methods Centre, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ontario, K1H 8 L6, Canada.; TRIBE Graduate Program, University of Split School of Medicine, Split, Croatia.
    Thuku M; Knowledge Synthesis Group, Ottawa Methods Centre, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ontario, K1H 8 L6, Canada.
    Butler C; Knowledge Synthesis Group, Ottawa Methods Centre, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ontario, K1H 8 L6, Canada.; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, H3A 2B4, Canada.
    Skidmore B; Ottawa, Canada.
    Wieland LS; Center for Integrative Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
    Clemons M; School of Epidemiology and Public Health, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, K1H 8 M5, Canada.; Division of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, Canada.
    Kanji S; School of Epidemiology and Public Health, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, K1H 8 M5, Canada.; Department of Pharmacy, The Ottawa Hospital, Ottawa, Canada.; Clinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, Canada.
    Hutton B; Knowledge Synthesis Group, Ottawa Methods Centre, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ontario, K1H 8 L6, Canada. .; School of Epidemiology and Public Health, University of Ottawa, 451 Smyth Road, Ottawa, Ontario, K1H 8 M5, Canada. .
    Pokaż więcej
    Źródło:
    Systematic reviews [Syst Rev] 2019 Dec 10; Vol. 8 (1), pp. 320. Date of Electronic Publication: 2019 Dec 10.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Review
    MeSH Terms:
    Drug-Related Side Effects and Adverse Reactions*
    Medical Marijuana/*therapeutic use
    Neoplasms/*drug therapy
    Neuralgia/*drug therapy
    Pain/*drug therapy
    Humans ; Muscle Spasticity/drug therapy ; Nausea/etiology ; Vomiting/etiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Outcomes after toxic alcohol poisoning: a systematic review protocol.
    Autorzy:
    Wang C; Department of Medicine, University of Ottawa, 162 Parkdale Avenue, Ottawa, Ontario, K1Y 1J8, Canada.; The Ottawa Hospital - Riverside Campus, 1967 Riverside Drive, Ottawa, Ontario, K1H 7W9, Canada.
    Samaha D; The Ottawa Hospital - Riverside Campus, 1967 Riverside Drive, Ottawa, Ontario, K1H 7W9, Canada.; Division of Nephrology, Department of Medicine, University of Ottawa, 1967 Riverside Drive, Ottawa, K1H 7W9, Ontario, Canada.
    Hiremath S; The Ottawa Hospital - Riverside Campus, 1967 Riverside Drive, Ottawa, Ontario, K1H 7W9, Canada.; Division of Nephrology, Department of Medicine, University of Ottawa, 1967 Riverside Drive, Ottawa, K1H 7W9, Ontario, Canada.; The Ottawa Hospital Research Institute, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada.
    Sikora L; Health Sciences Library, University of Ottawa, 451 Smyth Road, Ottawa, K1H 8M5, Ontario, Canada.
    Sood MM; The Ottawa Hospital - Riverside Campus, 1967 Riverside Drive, Ottawa, Ontario, K1H 7W9, Canada.; Division of Nephrology, Department of Medicine, University of Ottawa, 1967 Riverside Drive, Ottawa, K1H 7W9, Ontario, Canada.; The Ottawa Hospital Research Institute, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada.
    Kanji S; The Ottawa Hospital Research Institute, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada.
    Clark EG; The Ottawa Hospital - Riverside Campus, 1967 Riverside Drive, Ottawa, Ontario, K1H 7W9, Canada. .; Division of Nephrology, Department of Medicine, University of Ottawa, 1967 Riverside Drive, Ottawa, K1H 7W9, Ontario, Canada. .; The Ottawa Hospital Research Institute, University of Ottawa, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada. .
    Pokaż więcej
    Źródło:
    Systematic reviews [Syst Rev] 2018 Dec 28; Vol. 7 (1), pp. 250. Date of Electronic Publication: 2018 Dec 28.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Ethylene Glycol*/toxicity
    Methanol*/toxicity
    Treatment Outcome*
    Humans ; Antidotes/therapeutic use ; Clinical Protocols/standards ; Renal Dialysis/methods ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews.
    Autorzy:
    Wolfe D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Yazdi F; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Kanji S; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; Department of Pharmacy, The Ottawa Hospital, Ottawa, Ontario, Canada.
    Burry L; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
    Beck A; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Butler C; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Esmaeilisaraji L; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Hamel C; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Hersi M; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Skidmore B; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
    Moher D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Hutton B; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 Oct 11; Vol. 13 (10), pp. e0205426. Date of Electronic Publication: 2018 Oct 11 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
    MeSH Terms:
    Drug-Related Side Effects and Adverse Reactions/*epidemiology
    Inpatients/*statistics & numerical data
    Canada/epidemiology ; Drug-Related Side Effects and Adverse Reactions/etiology ; Humans ; Incidence ; Pharmacovigilance ; Prospective Studies ; Retrospective Studies ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.
    Autorzy:
    Breau RH; Ottawa Hospital Research Institute, Ottawa, ON, Canada. .; Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada. .
    Lavallée LT; Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
    Cnossen S; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Witiuk K; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Cagiannos I; Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
    Momoli F; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Bryson G; Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Anesthesiology and Pain Medicine, University of Ottawa and Ottawa Hospital, Ottawa, ON, Canada.
    Kanji S; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Morash C; Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
    Turgeon A; CHU de Québec, Université Laval, Québec City, QC, Canada.
    Zarychanski R; Department of Internal Medicine, Section of Medical Oncology and Haematology, University of Manitoba, Winnipeg, MB, Canada.
    Mallick R; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Knoll G; Division of Urology, Department of Surgery, The Ottawa Hospital, Ottawa, ON, Canada.
    Fergusson DA; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Pokaż więcej
    Źródło:
    Trials [Trials] 2018 May 02; Vol. 19 (1), pp. 261. Date of Electronic Publication: 2018 May 02.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Blood Transfusion*
    Cystectomy*/adverse effects
    Antifibrinolytic Agents/*administration & dosage
    Blood Loss, Surgical/*prevention & control
    Tranexamic Acid/*administration & dosage
    Urinary Bladder Neoplasms/*surgery
    Antifibrinolytic Agents/adverse effects ; Canada ; Double-Blind Method ; Drug Administration Schedule ; Humans ; Infusions, Intravenous ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Time Factors ; Tranexamic Acid/adverse effects ; Treatment Outcome ; Urinary Bladder Neoplasms/pathology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis.
    Autorzy:
    Balijepalli C; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
    Druyts E; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
    Zoratti MJ; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
    Wu P; Canadian College of Naturopathic Medicine, Toronto, ON, Canada.
    Kanji S; Department of Pharmacy, The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Rabheru K; Department of Psychiatry, Ottawa Hospital, Ottawa, ON, Canada.
    Yan K; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
    Thorlund K; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
    Pokaż więcej
    Źródło:
    Schizophrenia research and treatment [Schizophr Res Treatment] 2018 Apr 01; Vol. 2018, pp. 1543034. Date of Electronic Publication: 2018 Apr 01 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Incidence, causes, and consequences of preventable adverse drug events: protocol for an overview of reviews.
    Autorzy:
    Hutton B; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada. .; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada. .
    Kanji S; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.; The Ottawa Hospital, Ottawa, Canada.
    McDonald E; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.; The Ottawa Hospital, Ottawa, Canada.
    Yazdi F; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
    Wolfe D; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
    Thavorn K; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada.; Institute of Clinical and Evaluative Sciences (ICES uOttawa), Ottawa, Canada.
    Pepper S; Health Canada, Marketed Health Products Directorate, Ottawa, Canada.
    Chapman L; Health Canada, Marketed Health Products Directorate, Ottawa, Canada.
    Skidmore B; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.
    Moher D; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Canada.
    Pokaż więcej
    Źródło:
    Systematic reviews [Syst Rev] 2016 Dec 05; Vol. 5 (1), pp. 209. Date of Electronic Publication: 2016 Dec 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Drug-Related Side Effects and Adverse Reactions*/epidemiology
    Drug-Related Side Effects and Adverse Reactions*/etiology
    Drug-Related Side Effects and Adverse Reactions*/prevention & control
    Research Design*
    Review Literature as Topic*
    Evidence-Based Medicine/*methods
    Drug Prescriptions ; Humans ; Incidence ; Medical Order Entry Systems ; Medication Adherence ; Medication Errors/prevention & control ; Medication Errors/statistics & numerical data ; Patient Education as Topic ; Patient Safety/standards ; Risk Factors ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Comparison of sedation strategies for critically ill patients: a protocol for a systematic review incorporating network meta-analyses.
    Autorzy:
    Hutton B; Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Rd, Ottawa, ON, K1H8L6, Canada. .; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada. .
    Burry LD; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.; Department of Pharmacy, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G1X5, Canada.
    Kanji S; Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Rd, Ottawa, ON, K1H8L6, Canada.; Department of Pharmacy, The Ottawa Hospital, Ottawa, ON, Canada.
    Mehta S; Department of Medicine, Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.; Department of Medicine, Division of Critical Care, Mount Sinai Hospital, Toronto, ON, Canada.
    Guenette M; Department of Pharmacy, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G1X5, Canada.
    Martin CM; Department of Medicine, Division of Critical Care, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; Lawson Health Research Institute, London Health Sciences Centre, London, ON, Canada.
    Fergusson DA; Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Rd, Ottawa, ON, K1H8L6, Canada.; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Adhikari NK; Department of Medicine, Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Evaluative Clinical Sciences, Trauma, Emergency and Critical Care Research Program, Sunnybrook Research Institute, Toronto, ON, Canada.
    Egerod I; University of Copenhagen, Rigshospitalet, Neurointensive Intensive Care, Copenhagen O, Denmark.
    Williamson D; Faculté de Pharmacie, Université de Montréal, Montreal, QC, Canada.; Département de Pharmacie, Hôpital du Sacré-Coeur, Montreal, QC, Canada.
    Straus S; Knowledge Translation Program, Li Ka Shing Knowledge Institute, Saint Michael's Hospital, Toronto, ON, Canada.
    Moher D; Clinical Epidemiology Program, Ottawa Hospital Research Institute, The Ottawa Hospital, General Campus, 501 Smyth Rd, Ottawa, ON, K1H8L6, Canada.; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON, Canada.; Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
    Ely EW; Department of Medicine, Vanderbilt University Medical Center, Health Services Research Center, Nashville, TN, USA.
    Rose L; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Evaluative Clinical Sciences, Trauma, Emergency and Critical Care Research Program, Sunnybrook Research Institute, Toronto, ON, Canada.; Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada.; Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.; Provincial Centre of Weaning Excellence, Toronto East General Hospital, Toronto, ON, Canada.
    Pokaż więcej
    Źródło:
    Systematic reviews [Syst Rev] 2016 Sep 20; Vol. 5 (1), pp. 157. Date of Electronic Publication: 2016 Sep 20.
    Typ publikacji:
    Journal Article; Meta-Analysis
    MeSH Terms:
    Network Meta-Analysis*
    Conscious Sedation/*methods
    Critical Illness/*therapy
    Humans ; Length of Stay ; Quality of Life ; Respiration, Artificial ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.
    Autorzy:
    Hutton B; Ottawa Hospital Research Institute, Ottawa, Canada. .; University of Ottawa School of Epidemiology, Public Health and Preventive Medicine, Ottawa, Canada. .
    Yazdi F; Ottawa Hospital Research Institute, Ottawa, Canada. .
    Bordeleau L; Department of Oncology, McMaster University, Hamilton, Ontario, Canada. .
    Morgan S; Division of Radiation Oncology, Department of Radiology, University of Ottawa, Ottawa, Canada. .
    Cameron C; Cornerstone Research Group, Toronto, Canada. .
    Kanji S; Ottawa Hospital Research Institute, Ottawa, Canada. .
    Fergusson D; Ottawa Hospital Research Institute, Ottawa, Canada. .; University of Ottawa School of Epidemiology, Public Health and Preventive Medicine, Ottawa, Canada. .
    Tricco A; Li Ka Shing Knowledge Institute, St Mike's Hospital, Toronto, Canada. .
    Straus S; Li Ka Shing Knowledge Institute, St Mike's Hospital, Toronto, Canada. .
    Skidmore B; Ottawa Hospital Research Institute, Ottawa, Canada. .
    Hersi M; Ottawa Hospital Research Institute, Ottawa, Canada. .
    Pratt M; Ottawa Hospital Research Institute, Ottawa, Canada. .
    Mazzarello S; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital, Ottawa, Canada. .
    Brouwers M; Department of Oncology, McMaster University, Hamilton, Ontario, Canada. .
    Moher D; Ottawa Hospital Research Institute, Ottawa, Canada. .; University of Ottawa School of Epidemiology, Public Health and Preventive Medicine, Ottawa, Canada. .
    Clemons M; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital, Ottawa, Canada. .
    Pokaż więcej
    Źródło:
    Systematic reviews [Syst Rev] 2015 Aug 27; Vol. 4, pp. 114. Date of Electronic Publication: 2015 Aug 27.
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Complementary Therapies*
    Research Design*
    Breast Neoplasms/*complications
    Hot Flashes/*therapy
    Prostatic Neoplasms/*complications
    Female ; Hot Flashes/drug therapy ; Humans ; Male ; Systematic Reviews as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology.
    Autorzy:
    Lavergne V; Department of Medical Biology, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Quebec, Canada.
    Ouellet G
    Bouchard J
    Galvao T
    Kielstein JT
    Roberts DM
    Kanji S
    Mowry JB
    Calello DP
    Hoffman RS
    Gosselin S
    Nolin TD
    Goldfarb DS
    Burdmann EA
    Dargan PI
    Decker BS
    Hoegberg LC
    Maclaren R
    Megarbane B
    Sowinski KM
    Yates C
    Mactier R
    Wiegand T
    Ghannoum M
    Pokaż więcej
    Źródło:
    Seminars in dialysis [Semin Dial] 2014 Jul-Aug; Vol. 27 (4), pp. 407-14. Date of Electronic Publication: 2014 May 29.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Practice Guidelines as Topic*
    Poisoning/*therapy
    Renal Dialysis/*standards
    Delphi Technique ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-19 z 19

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies